Teladoc Health to Participate in Upcoming Investor Conference
NEW YORK, June 05, 2025 ( GLOBE NEWSWIRE ) -- Teladoc Health, Inc. ( NYSE: TDOC ) , the global leader in virtual care, announced today that Chuck Divita, chief executive officer, and Mala Murthy, chief financial officer, will participate in the Goldman Sachs 46th Annual Global Healthcare ...
Reviva to Participate in the H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference
CUPERTINO, Calif., June 05, 2025 ( GLOBE NEWSWIRE ) -- Reviva Pharmaceuticals Holdings, Inc. ( NASDAQ: RVPH ) ( "Reviva" or the "Company" ) , a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system ( CNS ) , ...
Nanox Receives MDR CE Mark for HealthOST, an Advanced AI-Powered Software for Spine Assessment
PETACH TIKVA, Israel, June 05, 2025 ( GLOBE NEWSWIRE ) -- NANO-X IMAGING LTD ( "Nanox" or the "Company", Nasdaq: NNOX ) , an innovative medical imaging technology company, today announced that its deep-learning medical imaging analytics subsidiary, Nanox AI Ltd, has received EU MDR CE ( ...
IREN May 2025 Monthly Update
SYDNEY, June 05, 2025 ( GLOBE NEWSWIRE ) -- IREN Limited ( NASDAQ: IREN ) ( together with its subsidiaries, "IREN" or "the Company" ) , today published its monthly update for May 2025.
Alpha Modus Appoints Tim Matthews as Head of Deployment Strategy to Accelerate CashX Rollout
Alpha Modus appoints Tim Matthews as Head of Deployment Strategy to lead national CashX rollout and drive AI-powered retail growth.
Worksport Announces Fall 2025 Launch of Highly Anticipated SOLIS & COR Nano-Grid System Following Completion of Major Engineering Milestones
Company Projects Millions in New 2025 Revenues. Modular Nano-Grid System Delivers 4,000Wh+ of Solar Generated Energy. Targeting Vehicles, Jobsites, Military, and Portable Power Markets.
Arvinas to Present Preclinical Data for PROTAC BCL6 Degrader, ARV-393, at the 2025 European Hematology Association ( EHA ) Annual Meeting
- Company to showcase preclinical studies of ARV-393, an investigational oral PROTAC BCL6 degrader, as a single agent in models of nodal T-follicular helper cell lymphoma, angioimmunoblastic-type ( AITL ) and transformed follicular lymphoma, and in combination with small molecule inhibitors in ...
CISO Global Successfully Completes SOC 2 Audit - Third Consecutive Year Marks Continued Commitment to Security and Trust
Scottsdale, AZ, June 05, 2025 ( GLOBE NEWSWIRE ) -- CISO Global Inc. ( NASDAQ: CISO ) , an industry leader in AI-powered security software, managed cybersecurity services, and compliance solutions, today announced its successful completion of its SOC 2 Type II examination.
TOMI Announces Appointment of David Vanston as Chief Financial Officer
FREDERICK, Md., June 05, 2025 ( GLOBE NEWSWIRE ) -- TOMI Environmental Solutions, Inc.® ( "TOMI" ) ( NASDAQ: TOMZ ) , a global company specializing in disinfection and decontamination solutions, today announced the appointment of Mr. David Vanston as Chief Financial Officer, effective May 30, ...
